What are you looking for?
Children with advanced myopia treated with nightly 0.01% atropine experienced slower myopia progression over 12 months than during untreated periods in a randomized crossover pilot trial. The 24-month open-label study enrolled 19 children with myopia of -4.50 D or greater, who were randomized to receive either 12 months of atropine followed by 12 months of... ...
Repeated low-level red-light (RLRL) therapy produced greater changes in 3D macular morphology than 0.01% low-dose atropine over 12 months in children with...
Monitoring axial length (AL) progression before treatment may help predict the effectiveness of optical myopia control interventions, according to a study. Researchers...
Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a...
Children with advanced myopia treated with nightly 0.01% atropine experienced slower myopia progression over 12 months than during untreated periods in a randomized crossover pilot trial. The 24-month open-label study...
Repeated low-level red-light (RLRL) therapy produced greater changes in 3D macular morphology than 0.01% low-dose atropine over 12 months in children with myopia, according to a study. The secondary analysis...
Monitoring axial length (AL) progression before treatment may help predict the effectiveness of optical myopia control interventions, according to a study. Researchers evaluated 128 eyes from 64 pediatric patients who...
Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a study. The retrospective matched-cohort study 1,012 children and...
Thirty minutes of tablet use in children with myopia reduced tear film stability and worsened some symptoms of eye strain, according to a study, which also found a higher screen...
Children with myopia who were treated with atropine showed a link between the timing of peak height growth and periods of faster ocular axial elongation, according to a study. Researchers...
Three-dimensional eye shape may help predict long-term outcomes in high myopia, according to a 15-year cohort study. Researchers found that nasally distorted and conical eye shapes were associated with faster...
Young adults wearing myopia control (MC) spectacle lenses with peripheral defocus maintained normal central visual acuity and contrast sensitivity, but experienced significant reductions in off-axis vision and slower task completion...
A meta-analysis of randomized clinical trials found that atropine slowed myopia progression in children across a range of concentrations, though benefits appeared to level off at higher doses while side...
Low-dose atropine did not significantly slow myopia progression in children with inherited retinal diseases (IRDs) after accounting for age-related changes, according to a study. Low-dose atropine shows limited effect on...
Low-dose atropine and Defocus Incorporated Multiple Segments (DIMS) lenses helped stabilize refractive development in preschool children at high familial risk for myopia, according to a study presented at the ARVO...
A 2-year interim analysis of the Myopia Atropine Dose (MAD) randomized clinical trial found modest axial elongation in children treated with atropine. The findings were presented in a poster at...
Nearly one-quarter of myopic schoolchildren experience dry eye symptoms that are mainly associated with reduced tear volume, according to a study. The study included 224 children aged 7 to 14...
